Assessment of gastric antisecretory effects of phenoxyisobutyrate derivatives in the rat and the mouse.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Scandinavian Journal of Gastroenterology

• Publication date

  1988-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/00365528809090170PMID 3247588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoproteins and coronary heart disease.

  1989cited by this paper
• The Toxicological Consequences of the Gastric Antisecretory Activity of Ciprofibrate in the Rat

  1988cited by this paper
• Drugs Affecting Lipid Metabolism

  1988cited by this paper
• Use of a five-day test to predict the long-term effects of gastric antisecretory agents on serum gastrin in rats.

  1987cited by this paper
• Pharmacology and toxicology of omeprazole--with special reference to the effects on the gastric mucosa.

  1986cited by this paper
• Effect of clofibrate on cholesterol metabolism in rats treated with polychlorinated biphenyls

  1986cited by this paper
• Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

  1986cited by this paper
• Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histidine decarboxylase activity and ECL cell density in normal and antrectomized rats.

  1986cited by this paper
• Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade.

  1986cited by this paper
• Effect of acid inhibition on gastric endocrine cells.

  1986cited by this paper
• Hiatus hernia in gastroesophageal reflux disease.

  1986cited by this paper
• Gastrin and the trophic control of gastric mucosa.

  1986cited by this paper
• Antisecretory drugs and gastric cancer.

  1985cited by this paper
• Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.

  1985cited by this paper
• Pharmacological studies on Linderae umbellatae Ramus, IV. Effects of condensed tannin related compound on peptic activity and stress-induced gastric lesions in mice.

  1985cited by this paper
• Toxicological studies on omeprazole.

  1985cited by this paper
• Pharmacological Studies on Linderae umbellatae Ramus, IV*. Effects of Condensed Tannin Related Compounds on Peptic Activity and Stress-Induced Gastric Lesions in Mice.

  1985cited by this paper
• The gastric antisecretory effects of clofibrate in the rat.

  1982cited by this paper
• Ciprofibrate in the therapy of type II hypercholesterolemia. A double-blind trial.

  1982cited by this paper
• Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man.

  1981cited by this paper
• Metabolic disposition of antihyperlipidemic agents in man and laboratory animals.

  1980cited by this paper
• The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.

  1979cited by this paper
• Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug.

  1979cited by this paper
• Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidemic agent.

  1979cited by this paper
• Clofibrate: antisecretory‐antiulcer activity in the rat

  1976cited by this paper
• Inhibition of gastric secretion by medium-chain triglycerides in bile-diverted rats

  1972cited by this paper

• Gastroprotective effect of bezafibrate, a peroxisome proliferator activated receptor α agonist and its mechanism in a rat model of aspirin‐induced gastric ulcer

  2016influential citation
• Role of peroxisome proliferator-activated receptors alpha and gamma in gastric ulcer: An overview of experimental evidences.

  2015cites this paper
• Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR α Running head : Mechanisms of ciprofibrate-induced hypergastrinemia

  2005cites this paper
• Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-alpha.

  2005cites this paper
• Antral G cells in rats during dosing with a PPARα agonist: a morphometric and immunocytochemical study

  2003cites this paper
• Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPARA receptors

  2003cites this paper
• Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia.

  2000cites this paper
• The peroxisome-proliferator ciprofibrate induces hypergastrinemia without raising gastric pH.

  1996cites this paper
• The role of investigative toxicology in pharmaceutical industry.

  1994cites this paper
• Sustained suppression of gastric secretion and the risk of neoplasia in the gastric mucosa.

  1991cites this paper
• Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach.

  1991cites this paper
• The importance of pharmacokinetic and receptor studies in drug safety evaluation.

  1990cites this paper
• Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.

  1990cites this paper
• Gastric Morphological Changes Including Carcinoid Tumors in Animals Treated with a Potent Hypolipidemic Agent, Ciprofibrate

  1989cites this paper
• The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat.

  1989cites this paper
• The trophic effects of gastrin on fundic neuroendocrine cells of the rat stomach

  1989cites this paper